Dr Fintan Walton is the Founder and CEO of PharmaVentures . After completing his doctoral research on the genetics of cell proliferation at the University of Michigan(US)and Trinity College (Dublin, Ireland), Dr Walton gained broad commercial experience in biotechnology in management positions at Bass and Celltech plc (1982-1992).
James Sabry
Vice President
James Sabry MD, PhD., has been the Chief Executive Officer and President of Ar"te Therapeutics Inc., since July 2008. Dr. Sabry co-founded Cytokinetics Incorporated., in August 1997 and has been its Consultant since April 1, 2008. James Sabry serves as Vice President of Partnering at Genentech, Inc. He has a wealth of drug discovery, development, and biotechnology management experience. Dr. Sabry served as the Chief Executive Officer of Cytokinetics Incorporated, from August 1997 to January 2006 and also as its President from August 1997 to February 2006. He has been the Chairman of Scientific Advisory Board at Cytokinetics Incorporated, since April 1, 2008. Dr. Sabry served as an Executive Chairman of Cytokinetics Incorporated, from January 22, 2007 to March 31, 2008 and also served as its Chairman from April 1, 2008 to March 16, 2010. He is a Member of Dean's Council of the Kennedy School of Government at Harvard University. He serves as a Director of HopeLab and Arete Therapeutics Inc. He served as an Executive Director of Cytokinetics Incorporated from August 1997 to March 16, 2010. He serves as a Member of Advisory Boards of California Institute of Quantitative Biosciences. He held faculty positions at the University of California, San Francisco and Harvard Medical School from 1984 to 1987. Dr. Sabry received a M.D. from Queen's University and a PhD in Cell Biology from the University of California, San Francisco.